Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults
Open Access
- 30 January 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (2) , 178
Abstract
This study aims to investigate the effect of antipsychotic agents on cardiovascular and cerebrovascular diseases (CVD/CEV) and mortality risks in the older population living in a community. A cohort of 42,650 new users of antipsychotic agents was built using Quebec healthcare databases (1998–2011). The outcomes were CVD/CEV and mortality incidence in 5 years of follow-up in the total cohort, sub-cohort of patients with no schizophrenia/dementia, sub-cohort with schizophrenia, and sub-cohort with dementia. Comparisons were made between the new users who continued the treatment (adherent level ≥ 60%) vs. those ceasing treatment (adherence level < 60%) using inverse probability of treatment weighting and Cox models. Comparing high adherence vs. low levels, CVD/CEV risk was increased by 36% in the sub-cohort with schizophrenia for atypical antipsychotic users and by 25% in the sub-cohort with dementia for typical antipsychotic users. An increasing mortality risk of 2- to 3-fold was linked with the typical antipsychotic use in all cohorts except the sub-cohort with schizophrenia; in addition, mortality risk is linked with the use of high vs. low doses. Antipsychotics were not linked with CVD/CEV risk, except for atypical antipsychotics in patients with schizophrenia and typical antipsychotics in patients with dementia. The mortality risk was linked with the use of typical antipsychotics and the dose used.Keywords
Funding Information
- Réseau québécois de recherche sur les médicaments (RQRM)
- University of Ottawa Heart Institute Foundation and the Whit & Heather Tucker Endowed Funds (Ottawa, Canada)
- Fonds de Recherche du Québec—Santé (FRQS)
This publication has 48 references indexed in Scilit:
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Adverse drug reactions in special populations – the elderlyBritish Journal of Clinical Pharmacology, 2015
- Comorbidity of Depression with Physical Disorders: Research and Clinical ImplicationsChonnam Medical Journal, 2015
- Comparative mortality risks of antipsychotic medications in community-dwelling older adultsThe British Journal of Psychiatry, 2014
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and RecommendationsCirculation, 2014
- Depression and Medication Adherence in the Treatment of Chronic Diseases in the United States: A Meta-AnalysisJournal of General Internal Medicine, 2011
- Risk of Hospitalization for Stroke Associated with Antipsychotic Use in the ElderlyDrugs & Aging, 2010
- Risk of venous thromboembolism due to antipsychotic drug therapyExpert Opinion on Drug Safety, 2009
- Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al.Journal of Psychopharmacology, 2009
- Risk of Death With Atypical Antipsychotic Drug Treatment for DementiaJAMA, 2005